|
|
|
|
|
|
|
|
|
|
|
|
|
<PAGE> 1
EXHIBIT 11.1
A-FEM MEDICAL CORPORATION
CALCULATIONS OF NET LOSS PER SHARE
<TABLE>
<CAPTION>
FOR THE THREE MONTHS FOR THE NINE MONTHS
ENDED SEPTEMBER 30, ENDED SEPTEMBER 30,
-------------------------------- --------------------------------
2000 1999 2000 1999
----------- ----------- ----------- -----------
<S> <C> <C> <C> <C>
Actual weighted average shares
outstanding for the period 9,596,558 9,546,717 9,579,892 9,505,888
Dilutive common and preferred stock,
options and warrants using the
treasury stock method(1) -- -- -- --
----------- ----------- ----------- -----------
Total shares used in per
share calculations 9,596,558 9,546,717 9,579,892 9,505,888
----------- ----------- ----------- -----------
Net loss $ (486,417) $ (621,672) $(1,355,135) $(1,971,033)
----------- ----------- ----------- -----------
Basic and diluted net loss per share $ (0.05) $ (0.07) $ (0.14) $ (0.21)
=========== =========== =========== ===========
</TABLE>
(1) Preferred stock, warrants and options outstanding are not included, as the
effect would be anti-dilutive.
|
|